CNBX Pharmaceuticals Inc. (CNBX) Other Operating Expenses (2011 - 2023)

CNBX Pharmaceuticals' (CNBX) quarterly Other Operating Expenses came in at -$1.0 in Q1 2023, down 100.0% on a QoQ basis from $433730.0 in Q4 2020.

CNBX Pharmaceuticals Inc. (CNBX) Other Operating Expenses (2011 - 2023) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 11 years of Other Operating Expenses data on file, last reported at -$1.0 in Q1 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to -$1.0 in Q1 2023, while the trailing twelve-month figure through Nov 2023 was -$1.0 (changed N/A YoY) and the FY2024 annual result came in at -$88934.0, down 79.61% from the prior year.
Other Operating Expenses slipped to -$1.0 in Q1 2023, from $433730.0 in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $4.9 million in Q1 2019 to a low of -$1.0 in Q1 2023.
A 3-year average of $1.2 million and a median of $360946.5 in 2019 frame the typical range for Other Operating Expenses.
Annual changes were most pronounced in 2019 — Other Operating Expenses tumbled 71.3% — and 2020, when it jumped 1626.84%.
Tracing CNBX's Other Operating Expenses over 3 years: stood at $25117.0 in 2019, then jumped by 1626.84% to $433730.0 in 2020, then slumped by 100.0% to -$1.0 in 2023.
The last three Other Operating Expenses figures came in at -$1.0 (Q1 2023), $433730.0 (Q4 2020), and $1.7 million (Q3 2020), per Business Quant data.

Download Data